South Africa's experience of the closure of the cellulose sulphate microbicide trial
about
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristicsThe spread, treatment, and prevention of HIV-1: evolution of a global pandemicHIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectivenessThe impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.A comparative analysis of gene expression patterns and cell phenotypes between cervical and peripheral blood mononuclear cells.Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis.Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa.Quantitative assessment of microbicide-induced injury in the ovine vaginal epithelium using confocal microendoscopy."One teabag is better than four": Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South AfricaDissemination of research findings to research participants living with HIV in rural Uganda: challenges and rewardsEnzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles.Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials.Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South AfricaUse of high-resolution confocal imaging of the vaginal epithelial microstructure to detect microbicide toxicity.Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges.Rational design of novel HIV-1 entry inhibitors by RANTES engineeringPrevention of SHIV transmission by topical IFN-β treatment.High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicidesNon-Antiretroviral Microbicides for HIV Prevention.'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.Hesitance towards voluntary medical male circumcision in Lesotho: reconfiguring global health governance.Design of epidemiological studies measuring genital and plasma HIV-1 outcomes: lessons from a randomised controlled trial.Civil society perspectives on negative biomedical HIV prevention trial results and implications for future trials.HIV treatment proceeds as prevention research confounds.'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials.
P2860
Q21090521-3F6F9683-2989-4207-A866-CC72D9B6ACAEQ22241890-C62BEDEE-034A-4E31-9337-49CD1D80A4FBQ28474086-5A771BAA-581A-49DD-9F14-B3AD317226F1Q33332191-89D8C2A5-0F95-43DC-ABFD-0BB5F8AD9A46Q33518544-CE440731-D995-43A0-BDC2-82A8311B45FEQ33831737-AEA0B1FE-5A0F-4A80-8801-09EC23549C20Q33848578-64B0F5A3-A2CB-4A62-8193-C58F855026EFQ34178386-A34A2DB4-91DF-4545-B985-455B4066221BQ34510587-B9C8F5BE-F18C-4F71-A163-24492AA367D0Q34614224-F52BE23C-DC26-421E-B2A8-FDBD405D6863Q35027986-8CFD91B9-34DD-4634-A215-AC6A6E41BAA6Q35033732-A36469BD-C4DE-4170-A4CA-35437E7631B1Q35049812-2D773F18-6816-4F4A-9BA5-8CBEA8B5D3AFQ35062487-A687F077-BCDF-4C57-982B-F67608995F78Q35854819-1A32DBA8-094B-4F4A-8512-350E5D5F8EF7Q36748033-847FC3CB-AAA0-4EE7-BBFF-F2F0AA68A8F8Q36793736-B34D0A7A-FD26-4FB6-969E-4E337368E9EDQ37150111-6AAFA424-7B50-4AD2-BF41-27BEB5AE34CFQ37175433-5D13B6AF-B0FF-4002-82C0-7865350C5A21Q37317845-D7B1E132-B478-4B96-9D8C-B754C2860B58Q38868992-B11A45BE-91A5-49FA-9122-11797BA83D1CQ39116133-C1E7BDDE-F5F2-4142-8B4B-5EB98EA6C1A3Q39160892-14968677-BAA7-4A6E-B97B-155D378F699DQ39648796-C6687F2A-3058-4192-A13A-3D0C5ACAB841Q42738979-AA639977-6E8D-4146-A18D-E0E50567F31BQ43497184-0B6345E7-F8E4-4AF8-A2BD-9775EB27E135
P2860
South Africa's experience of the closure of the cellulose sulphate microbicide trial
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
South Africa's experience of the closure of the cellulose sulphate microbicide trial
@ast
South Africa's experience of the closure of the cellulose sulphate microbicide trial
@en
South Africa's experience of the closure of the cellulose sulphate microbicide trial.
@nl
type
label
South Africa's experience of the closure of the cellulose sulphate microbicide trial
@ast
South Africa's experience of the closure of the cellulose sulphate microbicide trial
@en
South Africa's experience of the closure of the cellulose sulphate microbicide trial.
@nl
prefLabel
South Africa's experience of the closure of the cellulose sulphate microbicide trial
@ast
South Africa's experience of the closure of the cellulose sulphate microbicide trial
@en
South Africa's experience of the closure of the cellulose sulphate microbicide trial.
@nl
P2093
P2860
P1433
P1476
South Africa's experience of the closure of the cellulose sulphate microbicide trial
@en
P2093
Anthony Mbewu
Neetha S Morar
Roshini Govinden
P2860
P356
10.1371/JOURNAL.PMED.0040235
P407
P50
P577
2007-07-01T00:00:00Z